Cleared Traditional

K091588 - UCP HOME DRUG SCREENING TESTS (FDA 510(k) Clearance)

Sep 2009
Decision
94d
Days
Class 2
Risk

K091588 is an FDA 510(k) clearance for the UCP HOME DRUG SCREENING TESTS. This device is classified as a Enzyme Immunoassay, Amphetamine (Class II - Special Controls, product code DKZ).

Submitted by Ucp Biosciences, Inc. (San Jose, US). The FDA issued a Cleared decision on September 4, 2009, 94 days after receiving the submission on June 2, 2009.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.3100.

Submission Details

510(k) Number K091588 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 02, 2009
Decision Date September 04, 2009
Days to Decision 94 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code DKZ — Enzyme Immunoassay, Amphetamine
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.3100

Similar Devices — DKZ Enzyme Immunoassay, Amphetamine

All 224
DRI Ecstasy Plus Assay
K240670 · Microgenics Corporation · Oct 2024
AllTest Multi-Drug Rapid Test Cup
K233019 · Hangzhou AllTest Biotech Co., Ltd. · Dec 2023
Xenta Drug Screen Cup, Xenta Drug Screen Dipcard
K231137 · Xenta Biomedical Science Co., Ltd. · May 2023
Quidel Triage® TOX Drug Screen, 94600
K200363 · Quidel Cardiovascular, Inc. · Mar 2020
Atlas Multi-Drugs Screening Test Cup, Atlas Multi-Drugs Screening Test Panel
K191099 · Atlas Medical · Oct 2019
Quidel Triage TOX Drug Screen, 94600
K182719 · Quidel Cardiovascular, Inc. · Jun 2019